Navigating the Peptide Landscape: Quality, Regulation, and Informed Choices

Podcast: Ageless Future · Regan Archibald

Opublikowano: 2026-05-13

In this presentation, Cade Archibald discusses the rapid growth of peptides and the increasing confusion surrounding their sourcing, regulation, and quality. He explains the distinction between regulated compounding pharmacies (such as 503A and 503B) and the rise of “research use only” (RUO) peptides, which are often marketed online without clear oversight or verification. Cade highlights concerns around inconsistent labeling, uncertain origins, and potential quality issues in the unregulated market, while emphasizing the importance of working with licensed professionals and verified pharmacies. He also outlines recent FDA categorization changes, ongoing reviews of certain peptides, and the broader regulatory environment shaping access and...